Unknown

Dataset Information

0

Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients.


ABSTRACT: Hepatotoxicity is a rare adverse event of methylprednisolone that should be considered in clinical practice. In patients at risk, we propose liver function surveillance, by measuring hepatic enzymes concentration 15-30 days after methylprednisolone administration. Additionally, we propose ACTH, dexamethasone, or plasma exchange as alternate treatment options for these patients.

SUBMITTER: Hidalgo de la Cruz M 

PROVIDER: S-EPMC5538224 | biostudies-other | 2017 Aug

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC4971042 | biostudies-literature
| S-EPMC9450381 | biostudies-literature
| S-EPMC6394431 | biostudies-literature
| S-EPMC5703548 | biostudies-literature
| S-EPMC3765009 | biostudies-literature
| S-EPMC7744876 | biostudies-literature
| S-EPMC8116391 | biostudies-literature
| S-EPMC4609048 | biostudies-literature
| S-EPMC6915691 | biostudies-literature
| S-EPMC2276246 | biostudies-literature